APO 040 (Omeprazole delayed release 40 mg)
Pill imprint APO 040 has been identified as Omeprazole delayed release 40 mg.
Omeprazole is used in the treatment of gerd; gastritis/duodenitis; erosive esophagitis; barrett's esophagus; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy. Omeprazole 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- APO 040
- 40 mg
- Pink / Brown
- 21.00 mm
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Apotex Corp.
- National Drug Code (NDC):
- Inactive Ingredients:
- magnesium hydroxide
methacrylic acid - ethyl acrylate copolymer (1:1) type a
ferric oxide red
More about omeprazole
- Omeprazole delayed-release capsules
- Omeprazole delayed-release oral suspension
- Omeprazole delayed-release tablets
- Omeprazole magnesium delayed-release capsules and tablets
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.